-
Review Comparative Study
Warfarin versus dabigatran: comparing the old with the new.
- Mary Elizabeth Abraham and Todd R Marcy.
- University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.
- Consult Pharm. 2012 Feb 1; 27 (2): 121-4.
AbstractWarfarin is an oral anticoagulant for treatment and prevention of venous and arterial thromboembolism. It requires regular monitoring and patient adherence to a variety of lifestyle factors that can influence its effect. Dabigatran is an oral direct thrombin-inhibitor recently approved for stroke prevention in atrial fibrillation. The primary advantages of dabigatran are freedom from monitoring, a short duration of action, and a limited number of factors influencing its effect. Primary disadvantages of dabigatran compared with warfarin are that less is known about its use, cost, and poor gastrointestinal tolerability. Clinical studies have revealed both agents to be effective, with comparable rates for major bleeding. Divergent recommendations have been offered by consensus guidelines. A patient-specific approach involving the perspectives of informed patients is most reasonable.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..